Form 8-K - Current report:
SEC Accession No. 0001193125-12-430801
Filing Date
2012-10-23
Accepted
2012-10-23 07:03:04
Documents
4
Period of Report
2012-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d427698d8k.htm 8-K 20392
2 FORM OF WARRANTS TO PURCHASE SHARES OF COMMON STOCK, DATED OCTOBER 22, 2012 d427698dex41.htm EX-4.1 84594
3 FORM OF SUBSCRIPTION AGREEMENT BY AND AMONG THE COMPANY AND THE PURCHASERS d427698dex101.htm EX-10.1 144395
4 FORM OF REGISTRATION RIGHTS AGREEMENT d427698dex102.htm EX-10.2 125390
  Complete submission text file 0001193125-12-430801.txt   376145
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 121155603
SIC: 2835 In Vitro & In Vivo Diagnostic Substances